半岛网络真人网

中国医药行业市场研究分析(英文105页)

发布：11-17 浏览: 来源:

中国医药行业市场研究分析(英文105页)

Table of Contents

IMS MARKET PROGNOSIS .........6

MARKET OVERVIEW AND FORECASTS .........7

MARKET SYNOPSIS ............ 7
TOTAL MARKET FORECASTS 2012-2016 ........... 9
ANALYSIS OF REBATES AND DISCOUNTS .............. 9
SUMMARY OF THE PROGNOSIS .......... 9
HOSPITAL SECTOR OVERVIEW ............. 11
HOSPITAL SECTOR FORECASTS ........ 13
EVENT ANALYSIS ............. 15
FORECASTING DATA AND METHODS ............. 20
DATA SOURCES ........... 20
BASELINE EXTRAPOLATIONS ........... 20
HOSPITAL SECTOR BASELINE EXTRAPOLATIONS ........... 21
ECONOMIC INDICATORS ........ 22
THERAPEUTIC CLASS FORECASTS ........ 23
IMS MARKET PROGNOSIS REPORT ...........25
BUSINESS ENVIRONMENT ...............26
ECONOMIC ENVIRONMENT ......... 26
ECONOMIC GROWTH ............. 26
INFLATION ......... 26
POPULATION, EMPLOYMENT AND INCOME ........... 26
FISCAL POLICY ............. 27
MONETARY POLICY ................ 27
FOREIGN TRADE AND CURRENT ACCOUNT ........... 27
EXCHANGE RATE .......... 28
POLITICAL ENVIRONMENT .......... 30
POLITICAL INSTITUTIONS ............... 30
CURRENT GOVERNMENT ......... 30
18th PARTY CONGRESS 2012 ........... 31
WUKAN VILLAGE PROTEST .............. 32

INTERNATIONAL RELATIONS ............ 32

HEALTHCARE ENVIRONMENT ...........33

HEALTHCARE PROVISION ........... 33
Market Prognosis Scenario 2012-2016: Healthcare Provision ............. 33
HEALTHCARE SYSTEM ............ 34
HEALTH STATUS ........... 36
HEALTHCARE FINANCING AND EXPENDITURE ............... 38
 
PHARMACEUTICAL EXPENDITURE .............. 38
HEALTHCARE POLICY ............. 41
DRUG POLICY .............. 42
HEALTH INSURANCE .............. 43
HOSPITAL SECTOR ................ 45
HOSPITAL DRUG PROCUREMENT ............... 48
COMMUNITY CARE ........ 50
PRESCRIBING AND DISPENSING .......... 52
Market Prognosis Scenario 2012-2016: Prescribing and Dispensing ............. 52
PRESCRIBING INFLUENCES .............. 52
ANTIBIOTIC PRESCRIBING .............. 55
ESSENTIAL DRUG LIST ........... 56
NATIONAL REIMBURSEMENT DRUG LIST ............. 56
PATIENT CO-PAYMENT ........... 58
HOSPITAL FORMULARIES ................ 58
PRESCRIPTION-ONLY POLICY ........... 58
SEPARATION OF PRESCRIBING AND DISPENSING .......... 58
PRICING ................ 59
Market Prognosis Scenario 2012-2016: Pricing .............. 59
PRICING SYSTEM ......... 59
PRICING POLICY REFORM ................ 60
PRICE MONITORING .............. 62
PRICE CUTS ........ 62
PRICE TRENDS ............. 63
PHARMACOECONOMICS ......... 64
DISCOUNTS AND MARGINS ............. 64
REGULATORY ENVIRONMENT ............... 66
Market Prognosis Scenario 2012-2016: Regulatory Environment ........ 66
STATE FOOD AND DRUG ADMINISTRATION ......... 67
PRODUCT REGISTRATION ................ 67
CLINICAL TRIALS ......... 68
GOOD MANUFACTURING PRACTICE ............ 68
POST-MARKETING SURVEILLANCE ............. 69
MARKETING AND PROMOTION ......... 69
COUNTERFEITS ............ 70
INTELLECTUAL PROPERTY ................ 70
PHARMACEUTICAL BUSINESS ENVIRONMENT .......... 72
Market Prognosis Scenario 2012-2016: Pharmaceutical Business Environment ................ 72
OPERATING ENVIRONMENT ............. 73
INDUSTRY STRUCTURE .......... 74
LEADING CORPORATIONS ............... 76
LEADING PRODUCTS .............. 77
FOREIGN INVESTMENT ........... 77
RESEARCH AND DEVELOPMENT ........ 78
GENERICS MARKET ................ 79
DISTRIBUTION ............. 80
RETAIL PHARMACY ................ 81
OTC MARKET ............... 82
SALES AND MARKETING ......... 83

APPENDIX A: GLOSSARY ........85

APPENDIX B: SOURCES AND METHODS .............87

COVERAGE ............. 87
MARKET FORECASTS ............. 88
MARKET SEGMENTATION FORECASTS ........ 88
THERAPEUTIC CLASS FORECASTS ............. 88
REGIONAL OVERVIEWS .......... 89
FORECASTING METHODOLOGY ............ 90
TOTAL MARKET FORECASTING PROCESS ............. 90
MARKET SEGMENTATION FORECASTING PROCESS ........ 91
THERAPEUTIC CLASS FORECASTING PROCESS .............. 93
SOURCES ............... 94
PRIMARY AND SECONDARY MARKET RESEARCH ............ 94
PHARMACEUTICAL MARKET DATA .............. 94
PHARMACEUTICAL MARKET COVERAGE .......... 95
EVENT IMPACT CALCULATION .............. 96
DEMOGRAPHIC CHANGES ................ 96
NEW PRODUCT LAUNCHES ............... 99
CALCULATION OF GENERIC COMPETITION ........... 99
USEFUL DEFINITIONS .............. 101
COMPOUND ANNUAL GROWTH RATE ........ 101
CONSTANT PRICE ................ 101
LASPEYRES INDEX ............... 101
STANDARD UNITS ............... 102
GENERIC DEFINITION USING THE IMS MIDAS MARKET SEGMENTATION FEATURE ........ 102
GENERIC DEFINITION WITHOUT THE MARKET SEGMENTATION FEATURE ............ 103
[报告关键词]：   医药  

解锁完整报告，深入了解医药相关研究分析！

成为经济管理文库VIP会员，畅享海量报告免费下载特权！

会员类型 价格 特点
包月 VIP ¥299 /月 无限下载
包季 VIP (特惠) ¥799 /季 高性价比
包年 VIP ¥2999 /年 长期研究必备
立即升级VIP会员 免费注册体验
非会员下载： 本报告需 25 积分 (价值 25 元)。

您可以通过 并 充值 后下载，或 直接付款 获取。

(会员登录后可直接下载或扣除积分)

版权及侵权申诉说明

高效、专业、可靠——最快一周

AI 辅助MBA/EMBA论文写作 + 专家精修

利用人工智能大模型撰写；专家量身修改保证论文快速、高效、高质量完成

选择 服务项目 价格 (元) 预计时间 说明
500 3天 基于AI生成开题报告，专家审核修订，确保研究方向和框架清晰可行，负责通过。
2000 1周 AI辅助完成初稿，相关专家进行深度内容、逻辑、语言润色、格式和专业性把关。
2000 1周 （1）根据反馈意见，专业修改；（2）根据查重报告，进行针对性修改，降低重复率，专家审核确保质量。（需提供查重报告）
总计: 0.00 元

请至少选择一项服务。

商务服务

可以微信或者电话联系：18121118831

AI辅助写作

人工智能+专家精修

根据材料，人工智能写作，专家把关精修，最快一周完成

点击查看详细

商务文档撰写

提供商业计划书、投资计划书咨询、撰写和指导

商务咨询业务

服务企业、政府和投资者，提供各个产业可行性研究报告撰写和咨询服务

商务咨询业务

为企业提供物流园区规划咨询，包括市场调研、可行性、总体战略和运营规划等等

合作共赢，共创未来

需要行业报告相关资料和报告？

每年为数千个企事业和个人提供专业化服务；量身定制你需要的行业报告的资料和报告

相信我们！企业客户遍及全球，提供政府部门、生产制造企业、物流企业、快消品行业专业化咨询服务；个人客户可以提供各类经济管理资料、商业计划、PPT、MBA/EMBA论文指导等。

点此填写您的需求

15+年的经验，值得信赖

可以QQ联系我们：896161733；也可以电话：18121118831

**涉及个人信息严格保密，敬请放心